De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Stevanato Group Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Franco Stevanato

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	3.7yrs

Recente managementupdates

Recent updates

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Aug 21

Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 12

Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

May 07

Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Mar 15

Stevanato: Destocking And Valuation Risk (Rating Downgrade)

Mar 12

Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 09

Stevanato: Guidance Reiterated And Supportive Revenue Growth

Nov 22

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Oct 22

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Sep 15

Stevanato Group: Undeniable Quality, But Lacking Upside

Jun 14

Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Mar 05

Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma

Jan 24

There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Dec 28

Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line

Nov 08

An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

Aug 01

A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Apr 19

CEO

Franco Stevanato (51 yo)

less than a year

Tenure

Mr. Franco Stevanato has been Executive Chairman of the Board at Stevanato Group S.p.A. since February 18, 2021, and serves as its Chief Executive Officer since June 30, 2024. He was Chief Executive Office...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Franco Stevanato	CEO & Executive Chairman	less than a year	geen gegevens	geen gegevens
Marco Dal Lago	Chief Financial Officer	no data	geen gegevens	geen gegevens
Ugo Gay	Chief Operations Officer	less than a year	geen gegevens	geen gegevens
Lisa Miles	Chief Communication Officer & Senior VP of Investor Relations	no data	geen gegevens	geen gegevens
Paolo De Fabritiis	Chief HR Officer	less than a year	geen gegevens	geen gegevens
Mauro Stocchi	Chief Business Officer	5.8yrs	geen gegevens	geen gegevens
Riccardo Butta	President of Americas	2.7yrs	geen gegevens	geen gegevens

0.9yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van STVN wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.9 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Franco Stevanato	CEO & Executive Chairman	3.7yrs	geen gegevens	geen gegevens
Fabrizio Bonanni	Lead Independent Director	11.8yrs	geen gegevens	0.0038% € 208.5k
Donald Morel	Independent Director	6.8yrs	geen gegevens	0.017% € 921.2k
William Federici	Independent Director	3.4yrs	geen gegevens	0.017% € 944.6k
Fabio Buttignon	Independent Director	10.8yrs	geen gegevens	geen gegevens
Madhavan Balachandran	Independent Director	6.8yrs	geen gegevens	0.021% € 1.2m
Luciano Santel	Independent Director	less than a year	geen gegevens	geen gegevens
Karen Flynn	Independent Director	less than a year	geen gegevens	geen gegevens
Sergio Stevanato	Emeritus Chairman	no data	geen gegevens	geen gegevens
Alvise Spinazzi	Director	13.8yrs	geen gegevens	0.0012% € 66.0k
Paola Vezzaro	Independent Director	3.4yrs	geen gegevens	geen gegevens
Franco Moro	Director	3.7yrs	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

64.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van STVN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Stevanato Group Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Stevanato Group S.P.A. Announces Chief Executive Officer Changes

Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer

Chief Business Officer notifies of intention to sell stock

Stevanato Group S.p.A., Annual General Meeting, Jun 01, 2022

Stevanato Group Appoints Riccardo Butta as President, Americas

Recent updates

Stevanato Group S.p.A. to Introduce Its Large-Volume Vertiva 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan

Investor sentiment improves as stock rises 16%

Now 25% overvalued

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 26% overvalued

Stevanato Group S.p.A. Updates Earnings Guidance for the Year 2024

Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Stevanato Group S.p.A. to Report Q2, 2024 Results on Aug 06, 2024

Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 17%

Dividend of €0.053 announced

Stevanato Group S.P.A. Announces Chief Executive Officer Changes

Stevanato: Destock Pressures, Long-Term Upside

Consensus EPS estimates fall by 16%

Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 10% to US$31.41

Stevanato Group S.P.A. Provides Revenue Guidance for 2024

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 21%

Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

Stevanato Group S.p.A. to Report Q1, 2024 Results on May 09, 2024

Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

Stevanato Group S.p.A. has filed a Follow-on Equity Offering in the amount of $300 million.

Stevanato Group S.p.A. has filed a Follow-on Equity Offering in the amount of $300 million.

Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Stevanato: Destocking And Valuation Risk (Rating Downgrade)

New major risk - Earnings quality

Full year 2023 earnings: EPS misses analyst expectations

Stevanato Group S.P.A. Provides Revenue Guidance for the Full Year of 2024

Stevanato Group S.p.A. to Report Q4, 2023 Results on Mar 07, 2024

Now 21% overvalued after recent price rise

Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Stevanato Group S.p.A. Launches EZ-fill®? Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization

Now 20% overvalued

Stevanato: Guidance Reiterated And Supportive Revenue Growth

Stevanato Group S.P.A. Reiterates Revenue Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Stevanato Group S.p.A. to Report Q3, 2023 Results on Oct 31, 2023

Stevanato Group S.p.A. to Report Q3, 2023 Results on Oct 31, 2023

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Stevanato Group S.P.A. Provides Revenue Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Stevanato Group S.p.A. to Report Q2, 2023 Results on Jul 28, 2023

Stevanato Group: Undeniable Quality, But Lacking Upside

Stevanato Group S.p.A. Unveils Vertiva On-Body Delivery System Platform for Wide Range of Injectable Therapies and for Large Delivery Volumes (Up to 10mL)

Stevanato Group S.p.A. Announces Dividend, Payable on July 17, 2023

Price target increased by 8.1% to US$31.50

Stevanato Group S.p.A. Reiterates Earnings Guidance for the Year 2023

Chief Business Officer notifies of intention to sell stock

Consensus EPS estimates increase by 12%

Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Price target increased by 18% to US$25.88

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Stevanato Group S.p.A. to Report Q4, 2022 Results on Mar 02, 2023

Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma

Investor sentiment improved over the past week

There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Third quarter 2022 earnings: EPS exceeds analyst expectations

Stevanato Group S.P.A. Provides Revenue Guidance for the Full Year 2022

Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line

Gerresheimer AG and Stevanato Group Present EZ-Fill Smart™, a New and Innovative Ready-To-Fill Vial Platform

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Stevanato Group S.P.A. Provides Revenue Guidance for 2022

An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

Stevanato Group S.p.A. to Report Q2, 2022 Results on Aug 04, 2022